Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5776
Novavax
NVAX
$1.2B
| $17K | ﹤0.01% |
768
+467
| +155% | +$10.5K |
|
5777
NWPX Infrastructure Inc
NWPX
$1.19B
| $17K | ﹤0.01% |
883
+357
| +68% | +$5.95K |
|
5778
Impinj
PI
$4.62B
| $17K | ﹤0.01% |
418
-12,757
| -97% | -$537K |
|
5779
RBB Bancorp
RBB
$448M
| $17K | ﹤0.01% |
+740
| New | +$16.7K |
|
|
RC
5780
Ready Capital
RC
$258M
| $17K | ﹤0.01% |
1,064
+1,051
| +8,085% | +$15.9K |
|
5781
Safe Bulkers
SB
$795M
| $17K | ﹤0.01% |
6,140
+589
| +11% | +$1.68K |
|
5782
SSR Mining
SSRM
$5.32B
| $17K | ﹤0.01% |
+1,639
| New | +$16.7K |
|
5783
Telecom Argentina
TEO
$6.03B
| $17K | ﹤0.01% |
576
-3,324
| -85% | -$97.6K |
|
5784
Tejon Ranch
TRC
$457M
| $17K | ﹤0.01% |
858
+847
| +7,700% | +$17K |
|
5785
PUT
Unisys
UIS
$209M
| $17K | ﹤0.01% |
2,000
+200
| +11% | +$1.94K |
|
5786
PUT
ProShares VIX Short-Term Futures ETF
VIXY
$192M
| $17K | ﹤0.01% |
+7
| New | +$21.6K |
|
|
CUTR
5787
DELISTED
Cutera, Inc.
CUTR
| $17K | ﹤0.01% |
399
-975
| -71% | -$32.1K |
|
|
TUP
5788
DELISTED
Tupperware Brands Corporation
TUP
| $17K | ﹤0.01% |
261
-49,326
| -99% | -$3.04M |
|
|
FFG
5789
DELISTED
FBL Financial Group
FFG
| $17K | ﹤0.01% |
230
+137
| +147% | +$9.4K |
|
|
GHDX
5790
DELISTED
Genomic Health, Inc.
GHDX
| $17K | ﹤0.01% |
521
-1,661
| -76% | -$52.4K |
|
|
TRK
5791
DELISTED
Speedway Motorsports, Inc.
TRK
| $17K | ﹤0.01% |
775
+665
| +605% | +$13.4K |
|
|
CTRL
5792
DELISTED
Control4 Corporation
CTRL
| $17K | ﹤0.01% |
565
-7,175
| -93% | -$175K |
|
|
BRS
5793
DELISTED
Bristow Group, Inc.
BRS
| $17K | ﹤0.01% |
1,772
-10,408
| -85% | -$84.8K |
|
|
ENLK
5794
CALL
DELISTED
EnLink Midstream Partners, LP
ENLK
| $17K | ﹤0.01% |
+1,000
| New | +$16.2K |
|
|
FBNK
5795
DELISTED
First Connecticut Bancorp, Inc
FBNK
| $17K | ﹤0.01% |
627
+618
| +6,867% | +$15.7K |
|
|
FFKT
5796
DELISTED
Farmers Capital Bank Corp
FFKT
| $17K | ﹤0.01% |
413
-2,634
| -86% | -$101K |
|
|
QIWI
5797
CALL
DELISTED
QIWI PLC
QIWI
| $17K | ﹤0.01% |
1,000
-900
| -47% | -$16.9K |
|
|
ADVM
5798
DELISTED
Adverum Biotechnologies
ADVM
| $16K | ﹤0.01% |
445
-10,953
| -96% | -$304K |
|
5799
PUT
Accuray
ARAY
$32M
| $16K | ﹤0.01% |
4,100
+3,200
| +356% | +$13.7K |
|
5800
Arrow Financial
AROW
$659M
| $16K | ﹤0.01% |
571
+560
| +5,091% | +$14.8K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.